125 related articles for article (PubMed ID: 11948969)
1. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
Devi GR; Sprenger CC; Plymate SR; Rosenfeld RG
Prostate; 2002 May; 51(2):141-52. PubMed ID: 11948969
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
4. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
Stewart LV; Weigel NL
Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo.
Liu B; Lee KW; Li H; Ma L; Lin GL; Chandraratna RA; Cohen P
Clin Cancer Res; 2005 Jul; 11(13):4851-6. PubMed ID: 16000583
[TBL] [Abstract][Full Text] [Related]
7. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth.
Kaicer E; Blat C; Imbenotte J; Troalen F; Cussenot O; Calvo F; Harel L
Growth Regul; 1993 Sep; 3(3):180-9. PubMed ID: 7693099
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
[TBL] [Abstract][Full Text] [Related]
11. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
Zi X; Zhang J; Agarwal R; Pollak M
Cancer Res; 2000 Oct; 60(20):5617-20. PubMed ID: 11059749
[TBL] [Abstract][Full Text] [Related]
12. Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25.
Sato Y; Chen Z; Miyazaki K
Cancer Sci; 2007 Jul; 98(7):1055-63. PubMed ID: 17465992
[TBL] [Abstract][Full Text] [Related]
13. The amino-terminal region of insulin-like growth factor binding protein-3, (1-95)IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells.
Bernard L; Babajko S; Binoux M; Ricort JM
Biochem Biophys Res Commun; 2002 Apr; 293(1):55-60. PubMed ID: 12054563
[TBL] [Abstract][Full Text] [Related]
14. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
[TBL] [Abstract][Full Text] [Related]
15. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.
Drivdahl R; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Plymate SR
Oncogene; 2004 Jun; 23(26):4584-93. PubMed ID: 15077158
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and -6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid.
Drivdahl RH; Sprenger C; Trimm K; Plymate SR
Endocrinology; 2001 May; 142(5):1990-8. PubMed ID: 11316765
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts.
Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR
Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836
[TBL] [Abstract][Full Text] [Related]
18. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like growth factor binding protein-3 before and after neoadjuvant hormonal therapy in human prostate cancer tissues: correlation with histopathologic effects and biochemical recurrence.
Miyata Y; Sakai H; Kanda S; Igawa T; Hayashi T; Kanetake H
Urology; 2004 Jun; 63(6):1184-90. PubMed ID: 15183987
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M
Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]